Trimethoprim-sulfamethoxazole versus Placebo for Skin Abscesses After Incision and Drainage.

Trimethoprim-sulfamethoxazole versus Placebo for Skin Abscesses After Incision and Drainage.

Watkins Richard R

Infectious Disease Alert

2016

2016-04

The article discusses research published in the 2016 issue of the "New England Journal of Medicine" on a seven-day outpatient course of trimethoprim-sulfamethoxazole (TMP-SMX) as compared to placebo for skin abscesses after incision and drainage. The study examined the efficacy of TMP-SMX versus placebo in treating skin abscesses and determined the number of patients infected with methicillin-resistant Staphylococcus aureus (MRSA), as well as their susceptibility to TMP-SMX.

Placebo Effect; Human; Experimental Studies; Skin Diseases; Methicillin-Resistant Staphylococcus Aureus; Body Fluids; Drainage; Staphylococcal Infections; Surgical Wound; Trimethoprim-Sulfamethoxazole Combination; Abscess – Drug Therapy

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

73–74

7

35